GKHT Medical Technology Past Earnings Performance
Past criteria checks 4/6
GKHT Medical Technology's earnings have been declining at an average annual rate of -3%, while the Healthcare industry saw earnings growing at 4.2% annually. Revenues have been growing at an average rate of 4.9% per year. GKHT Medical Technology's return on equity is 6.4%, and it has net margins of 2.1%.
Key information
-3.0%
Earnings growth rate
-6.3%
EPS growth rate
| Healthcare Industry Growth | 7.0% |
| Revenue growth rate | 4.9% |
| Return on equity | 6.4% |
| Net Margin | 2.1% |
| Next Earnings Update | 29 Aug 2024 |
Recent past performance updates
Revenue & Expenses Breakdown
How GKHT Medical Technology makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
| Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
|---|---|---|---|---|
| 31 Mar 24 | 7,430 | 155 | 493 | 12 |
| 31 Dec 23 | 7,483 | 154 | 498 | 13 |
| 30 Sep 23 | 7,228 | 122 | 547 | 12 |
| 30 Jun 23 | 7,217 | 137 | 526 | 12 |
| 31 Mar 23 | 6,590 | 126 | 489 | 13 |
| 01 Jan 23 | 6,360 | 125 | 470 | 12 |
| 30 Sep 22 | 5,898 | 142 | 467 | 11 |
| 30 Jun 22 | 5,029 | 149 | 433 | 11 |
| 31 Mar 22 | 5,466 | 148 | 415 | 11 |
| 31 Dec 21 | 5,847 | 151 | 410 | 11 |
| 30 Sep 21 | 4,813 | 158 | 395 | 10 |
| 30 Jun 21 | 7,974 | 165 | 388 | 10 |
| 31 Mar 21 | 7,466 | 156 | 371 | 9 |
| 31 Dec 20 | 4,862 | 146 | 355 | 8 |
| 31 Dec 19 | 4,246 | 149 | 278 | 3 |
| 31 Dec 18 | 3,637 | 93 | 185 | 1 |
| 31 Dec 17 | 2,195 | 74 | 111 | 0 |
| 31 Dec 16 | 1,564 | 56 | 83 | 0 |
| 31 Dec 15 | 972 | 15 | 61 | 0 |
Quality Earnings: 301370 has high quality earnings.
Growing Profit Margin: 301370's current net profit margins (2.1%) are higher than last year (1.9%).
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: 301370's earnings have declined by 3% per year over the past 5 years.
Accelerating Growth: 301370's earnings growth over the past year (23.2%) exceeds its 5-year average (-3% per year).
Earnings vs Industry: 301370 earnings growth over the past year (23.2%) exceeded the Healthcare industry -1%.
Return on Equity
High ROE: 301370's Return on Equity (6.4%) is considered low.